COMPATIBILITY STUDIES OF RASAGILINE MESYLATE WITH SELECTED EXCIPIENTS FOR AN EFFECTIVE SOLID LIPID NANOPARTICLES FORMULATION

Abstract

Objective: Compatibility study is an important element that should be performed at the early development stage of stable and effective solid dosage form.Methods: The compatibility studies of drug with different polymers and surfactant were investigated by using different methods Fourier Transform Infrared Spectroscopy (FTIR), Differential Scanning Calorimetry (DSC) and Isothermal Stress Testing (IST). The compatibility study of Rasagiline mesylate was performed with Chitosan, Stearic acid and Poloxamer 407. Drug and polymer mixtures were prepared in 1:1 ratio and the compatibility study was performed at25°C±2/60%±5RHand 40°C±2/75%±5RHfor one month. The resulting compatible drug and excipients were used in the formulation of solid lipid nanoparticles by Microemulsion method.Results: FTIR Spectroscopy results suggest that there is good compatibility between the drug and polymers. DSCresults showed that interaction between Rasagiline mesylate and Chitosan,the other excipients were compatible with RM and the IST study results clearly indicate the stable nature of the Rasagiline mesylate. The prepared RM-SLNs formulation shows a mean particle size within the nanometre range. SEM confirmed the size and shape of RM-SLNs. The results of zeta potential indicates a narrow size distribution. The RM-SLNs were found to be with acceptable morphometric properties, narrow size distribution, high entrapment efficiencyand good stability after 3 months of storage at different conditions (25°C±2/60%±5RH and 40°C±2/75%±5RH).Conclusion: The FTIR, DSC and IST results shown that Stearic acid and Poloxamer 407were found to be compatible with Rasagilinemesylate. The Rasagiline mesylate loaded nanoscale solid lipid particles was successfully formulated with compatible excipients and it was found to be stable after accelerated stabilitystudies. 

Authors and Affiliations

Viveksarathi Kunasekaran, Kannan Krishnamoorthy

Keywords

Related Articles

IDENTIFICATION OF POTENT BROMODOMAIN4 (BRD4) INHIBITORS BY ENERGY-PHARMACOPHORE BASED VIRTUAL SCREENING TO TARGET BRD4-NUT MIDLINE CARCINOMA

Objective: Protein-protein interactions (PPI’s) have been used as a target in various diseases. One such major role of PPI’s comes when the protein Bromodomain4 (BRD4) reads the epigenetic changes in the histones and...

RNAI MEDIATED GENE SILENCING OF EIF3A: A POSSIBLE SOLUTION TO CONTROL BREAST CANCER

Objective: The eukaryotic translational initiation factor 3A (eIF3A) is reported to be over expressed in most breast cancer cells. In the present study, our aim is to suppress the over expression of eIF3A in human breast...

FACILE SYNTHESIS, SPECTRAL STUDIES, DFT CALCULATIONS AND BIOLOGICAL ACTIVITIES OF NOVEL NI (II), CU (II), AND PD (II) COMPLEXES OF THIADIAZOLE ANALOGS

Objective: A facile synthesis of some novel Schiff base derivatives of 2-substituted-5-amino-thiadiazoles along with their Ni (II), Cu (II), and Pd (II) complexes were achieved by sonication and the conventional method....

ANTIOXIDANT STUDIES ON METHANOL AND AQUEOUS EXTRACTS OF GYMNOSPORIA MONTANA PLANT

Objective: The main objective of this study was to evaluate the free radical scavenging activity of methanol (70%) and aqueous extract of G. montana leaves which is a traditionally used herb known for its hepatoprotectiv...

PHYTOCHEMICAL EVALUATION AND IN VITRO ANTIMICROBIAL AND ANTIOXIDANT STUDIES OF LEAF AND STEM BARK EXTRACTS OF POLYALTHIA FRAGRANS (DALZ.) BEDD.–AN ENDEMIC SPECIES OF WESTERN GHATS

Objective: Phytochemical constituents of various solvent extracts of leaf and stem bark of Polyalthia fragrans (Dalz.) Bedd were screened. Antimicrobial and antioxidant activities of the extracts were evaluated.Methods:...

Download PDF file
  • EP ID EP579160
  • DOI -
  • Views 55
  • Downloads 0

How To Cite

Viveksarathi Kunasekaran, Kannan Krishnamoorthy (2015). COMPATIBILITY STUDIES OF RASAGILINE MESYLATE WITH SELECTED EXCIPIENTS FOR AN EFFECTIVE SOLID LIPID NANOPARTICLES FORMULATION. International Journal of Pharmacy and Pharmaceutical Sciences, 7(1), 73-80. https://europub.co.uk/articles/-A-579160